FREMONT, Calif., April 27 /PRNewswire-FirstCall/ -- Protein Design Labs,
Inc. (PDL) (Nasdaq: PDLI) today announced that its financial results for the
first quarter ended March 31, 2004 will be released following the close of the
U.S. financial markets on Monday, May 2, 2005. PDL will hold a conference
call to discuss these results, the status of its clinical development
programs, its forward-looking information and guidance with respect to future
results, and review the status of its recently completed acquisition of ESP
Pharma, Inc. at 4:30 p.m. Eastern time on May 2, 2005. The call will be
hosted by Mr. Mark McDade, Chief Executive Officer, Mr. Glen Y. Sato, Senior
Vice President and Chief Financial Officer, and Dr. Steven Benner, Senior Vice
President and Chief Medical Officer.
The live webcast will be available through the PDL website: http://www.pdl.com.
Please connect to this website at least 15 minutes prior to the live webcast
to allow time for any software download that may be needed to hear the
webcast. Financial and statistical information to be discussed in the call
will be available on the PDL website immediately prior to the commencement of
the call. A replay will be available at http://www.pdl.com starting approximately one
hour after completion of the webcast.
An audio replay will also be available by telephone from approximately 7
p.m. Eastern time on May 2, 2005 through 11:59 p.m. Eastern time on May 6,
2005. To access the replay, dial 800-633-8284 from inside the United States
and 402-977-9140 from outside the United States; enter conference ID number
21245638.
Protein Design Labs is a leader in the development of humanized antibodies
to prevent or treat various disease conditions. PDL currently has antibodies
under development for autoimmune and inflammatory conditions, asthma and
cancer. PDL holds fundamental patents for its antibody humanization
technology. Further information on PDL is available at http://www.pdl.com or by
contacting James R. Goff, Senior Director, PDL Corporate Communications,
510-574-1421 or jgoff@pdl.com.
NOTE: Protein Design Labs and the PDL logo are registered U.S. trademarks
of Protein Design Labs, Inc.
SOURCE Protein Design Labs, Inc.
 back to top
Related links:
http://www.pdl.com
CONTACT:
James R. Goff, Senior Director, Corporate
Communications of Protein Design Labs, Inc., +1-510-574-1421, or
jgoff@pdl.com
|
